MIM
CDMO

Monashee Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Monashee Investment Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-16,618
Closed -$49K – 211
2018
Q1 		$49K Buy
+16,618
New +$51.3K 0.01% 135
2017
Q4 		– Hold
0
– – – 125

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Monashee Investment Management's CDMO Position: Q2 2018 in Review

Monashee Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2018, closing a stake of 16,618 shares — an estimated $49K sold.

Monashee Investment Management first reported a position in CDMO in Q1 2018 and held it in 1 quarter. The position peaked at $49K in Q1 2018. 81 funds tracked by Wall St. Rank hold CDMO as of Q2 2018.

  • Monashee Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Monashee Investment Management sold 16,618 Avid Bioservices, Inc. Common Stock shares in Q2 2018, an estimated $49K.
  • Monashee Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Monashee Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $49K in Q1 2018.
  • 81 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2018.

Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.